Multicystic Dysplastic Kidney (multicystic + dysplastic_kidney)

Distribution by Scientific Domains


Selected Abstracts


Multicystic dysplastic kidney and calyceal diverticulum , more of an association than a coincidence?

ANZ JOURNAL OF SURGERY, Issue 6 2010
Avi Raman MBBS, BSc(Med), MPH TM
No abstract is available for this article. [source]


Malignant retroperitoneal tumor arising in a multicystic dysplastic kidney of a girl with Schinzel,Giedion syndrome

INTERNATIONAL JOURNAL OF UROLOGY, Issue 12 2005
FUMI MATSUMOTO
Abstract, We report the first case of malignant retroperitoneal tumor arising in a multicystic dysplastic kidney of an 8-year-old girl with Schinzel-Giedion syndrome. Although conservative treatment has been regarded as the standard management for asymptomatic multicystic dysplastic kidney, prophylactic surgical removal should be considered for selected children with potential risk of malignancy. [source]


Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two-vessel cord, and hydrocele

PRENATAL DIAGNOSIS, Issue 13 2008
Jodi D. Hoffman
Abstract Objective The FASTER trial compared first and second trimester screening methods for aneuploidy. We examined relationships between maternal serum markers and common congenital anomalies in the pediatric outcome data set of 36 837 subjects. Methods We used nested case,control studies, with cases defined by the most common anomalies in our follow-up database, and up to four controls matched by enrollment site, maternal age and race, enrollment gestational age, and infant gender. Serum markers were dichotomized to , 2 or < 0.5 multiples of the median (MoM). Odds ratios (ORs) and 95% confidence intervals (CI) were estimated. Results Statistically significant (p < 0.05) associations were found between inhibin A , 2 MoM with fetal multicystic dysplastic kidney (MCDK) (OR = 27.5, 95% CI: 2.8,267.7) and two-vessel cord (OR = 4.22, 95% CI:1.6,10.9); hCG of , 2 MoM with MCDK (OR = 19.56, 95% CI: 1.9,196.2) and hydrocele (OR = 2.48, 95% CI: 1.3,4.6); and PAPP-A , 2.0 MoM with hydrocele (OR = 1.88, 95% CI:1.1,3.3). Conclusion In this large prospective study, significant associations were found between several maternal serum markers and congenital anomalies. This suggests potential additional benefits to screening programs that are primarily designed to detect aneuploidy. Copyright © 2008 John Wiley & Sons, Ltd. [source]